SCHEMBL4091304

SCHEMBL4091304

CCC(C)(C)NC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.41
RPS6KB1 P23443 1/20 0.39
CDK2 P24941 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
GSK3B P49841 1/20 0.39
RPS6KA3 P51812 1/20 0.39
CNR2 P34972 1/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 5/20 0.38
GRIN2C Q14957 2/20 0.38
MAPT P10636 3/20 0.37
POLB P06746 1/20 0.37
ABCC1 P33527 1/20 0.37
AIP O00170 1/20 0.36
SGTA O43765 1/20 0.36
TOMM70 O94826 1/20 0.36
STIP1 P31948 1/20 0.36
PPP5C P53041 1/20 0.36
FKBP4 Q02790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4085499 0.90 CNR2 (0.40) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4080989 0.82 CNR2 (0.46) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4086545 0.81 CNR2 (0.42) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4084751 0.80 CNR2 (0.58) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4085496 0.79 CNR2 (0.45) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4090409 0.79 ALDH1A1 (0.44) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4090667 0.78 RPS6KB1 (0.47) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4091334 0.78 ALDH1A1 (0.46) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL4092577 0.78 CNR2 (0.51) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B
SCHEMBL3745498 0.77 ABCC1 (0.51) MAPK1RPS6KB1CDK2MAPKAPK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090018114-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018114-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, GPR18 MAPK1 2019/4885RPS6KB1 780/4885CDK2 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.